Date published: 2025-12-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Dehydro Felodipine (CAS 96382-71-7)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
4-(2,3-Dichlorophenyl)-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Ethyl Methyl Ester
Application:
Dehydro Felodipine is the primary metabolite of Felodipine
CAS Number:
96382-71-7
Molecular Weight:
382.24
Molecular Formula:
C18H17Cl2NO4
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Dehydro Felodipine is a chemical compound that functions as a calcium channel blocker. It inhibits the influx of calcium ions into smooth muscle cells, leading to relaxation of the vascular smooth muscle and vasodilation. Dehydro Felodipine targets L-type calcium channels, blocking the entry of calcium ions into the cells. By doing so, it reduces the contractility of smooth muscle cells in the blood vessels, resulting in a decrease in peripheral vascular resistance. This mechanism of action ultimately leads to a reduction in blood pressure. At the molecular level, Dehydro Felodipine binds to the alpha-1 subunit of the L-type calcium channel, preventing the channel from opening and inhibiting the influx of calcium ions. This interaction with the calcium channel alters the membrane potential and intracellular calcium concentration, leading to the relaxation of vascular smooth muscle.


Dehydro Felodipine (CAS 96382-71-7) References

  1. Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine--and its potential clinical relevance.  |  Edgar, B., et al. 1992. Eur J Clin Pharmacol. 42: 313-7. PMID: 1577050
  2. Felodipine clinical pharmacokinetics.  |  Dunselman, PH. and Edgar, B. 1991. Clin Pharmacokinet. 21: 418-30. PMID: 1782737
  3. A population study of the pharmacokinetics of felodipine.  |  Blychert, E., et al. 1991. Br J Clin Pharmacol. 31: 15-24. PMID: 2015166
  4. Acute and steady-state pharmacokinetics and antihypertensive effects of felodipine in patients with normal and impaired renal function.  |  Larsson, R., et al. 1990. J Clin Pharmacol. 30: 1020-30. PMID: 2243149
  5. Antihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approaches.  |  Zisaki, A., et al. 2015. Curr Pharm Des. 21: 806-22. PMID: 25341854
  6. Contribution of the intestine to the first-pass metabolism of felodipine in the rat.  |  Wang, SX., et al. 1989. J Pharmacol Exp Ther. 250: 632-6. PMID: 2760845
  7. Grapefruit juice and drugs. How significant is the interaction?  |  Bailey, DG., et al. 1994. Clin Pharmacokinet. 26: 91-8. PMID: 8162660

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Dehydro Felodipine, 5 mg

sc-207513
5 mg
$268.00